AXT INC (AXTI) Stock Fundamental Analysis

NASDAQ:AXTI • US00246W1036

45.43 USD
+7.53 (+19.87%)
Last: Mar 2, 2026, 02:38 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

2

Taking everything into account, AXTI scores 2 out of 10 in our fundamental rating. AXTI was compared to 115 industry peers in the Semiconductors & Semiconductor Equipment industry. AXTI may be in some trouble as it scores bad on both profitability and health. AXTI is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • In the past year AXTI has reported negative net income.
  • AXTI had a negative operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: AXTI reported negative net income in multiple years.
  • In the past 5 years AXTI reported 4 times negative operating cash flow.
AXTI Yearly Net Income VS EBIT VS OCF VS FCFAXTI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M -10M -20M -30M

1.2 Ratios

  • With a Return On Assets value of -6.88%, AXTI is not doing good in the industry: 68.70% of the companies in the same industry are doing better.
  • With a Return On Equity value of -12.83%, AXTI is not doing good in the industry: 70.43% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -6.88%
ROE -12.83%
ROIC N/A
ROA(3y)-4.47%
ROA(5y)-0.97%
ROE(3y)-7.58%
ROE(5y)-1.78%
ROIC(3y)N/A
ROIC(5y)N/A
AXTI Yearly ROA, ROE, ROICAXTI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 -5

1.3 Margins

  • AXTI's Gross Margin of 11.97% is on the low side compared to the rest of the industry. AXTI is outperformed by 84.35% of its industry peers.
  • AXTI's Gross Margin has declined in the last couple of years.
  • The Profit Margin and Operating Margin are not available for AXTI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 11.97%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-29.88%
GM growth 5Y-16.71%
AXTI Yearly Profit, Operating, Gross MarginsAXTI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • AXTI does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • AXTI has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, AXTI has more shares outstanding
  • Compared to 1 year ago, AXTI has an improved debt to assets ratio.
AXTI Yearly Shares OutstandingAXTI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
AXTI Yearly Total Debt VS Total AssetsAXTI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

2.2 Solvency

  • An Altman-Z score of 7.97 indicates that AXTI is not in any danger for bankruptcy at the moment.
  • The Altman-Z score of AXTI (7.97) is better than 66.09% of its industry peers.
  • A Debt/Equity ratio of 0.35 indicates that AXTI is not too dependend on debt financing.
  • The Debt to Equity ratio of AXTI (0.35) is worse than 63.48% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.35
Debt/FCF N/A
Altman-Z 7.97
ROIC/WACCN/A
WACC10.96%
AXTI Yearly LT Debt VS Equity VS FCFAXTI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M

2.3 Liquidity

  • AXTI has a Current Ratio of 1.76. This is a normal value and indicates that AXTI is financially healthy and should not expect problems in meeting its short term obligations.
  • AXTI has a Current ratio of 1.76. This is in the lower half of the industry: AXTI underperforms 79.13% of its industry peers.
  • A Quick Ratio of 0.85 indicates that AXTI may have some problems paying its short term obligations.
  • AXTI has a Quick ratio of 0.85. This is amonst the worse of the industry: AXTI underperforms 89.57% of its industry peers.
Industry RankSector Rank
Current Ratio 1.76
Quick Ratio 0.85
AXTI Yearly Current Assets VS Current LiabilitesAXTI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • The earnings per share for AXTI have decreased strongly by -83.33% in the last year.
  • The Revenue for AXTI has decreased by -11.11% in the past year. This is quite bad
  • The Revenue has been decreasing by -1.53% on average over the past years.
EPS 1Y (TTM)-83.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
Revenue 1Y (TTM)-11.11%
Revenue growth 3Y-14.46%
Revenue growth 5Y-1.53%
Sales Q2Q%-8.22%

3.2 Future

  • AXTI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 68.18% yearly.
  • The Revenue is expected to grow by 32.81% on average over the next years. This is a very strong growth
EPS Next Y94.9%
EPS Next 2Y68.18%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year35.14%
Revenue Next 2Y32.81%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
AXTI Yearly Revenue VS EstimatesAXTI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M
AXTI Yearly EPS VS EstimatesAXTI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 -0.4

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • AXTI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for AXTI. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AXTI Price Earnings VS Forward Price EarningsAXTI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -500 -1K -1.5K -2K

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AXTI Per share dataAXTI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

  • AXTI's earnings are expected to grow with 68.18% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y68.18%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for AXTI!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

AXT INC

NASDAQ:AXTI (3/2/2026, 2:38:08 PM)

45.43

+7.53 (+19.87%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)02-19
Earnings (Next)04-29
Inst Owners34.36%
Inst Owner Change116.82%
Ins Owners1.85%
Ins Owner Change4.88%
Market Cap2.46B
Revenue(TTM)88.33M
Net Income(TTM)-22.98M
Analysts81.82
Price Target28.82 (-36.56%)
Short Float %8.78%
Short Ratio0.69
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)30.25%
Min EPS beat(2)-14.71%
Max EPS beat(2)75.2%
EPS beat(4)1
Avg EPS beat(4)-28.28%
Min EPS beat(4)-130.68%
Max EPS beat(4)75.2%
EPS beat(8)5
Avg EPS beat(8)2.35%
EPS beat(12)8
Avg EPS beat(12)7.78%
EPS beat(16)12
Avg EPS beat(16)13.48%
Revenue beat(2)1
Avg Revenue beat(2)12.04%
Min Revenue beat(2)-10.9%
Max Revenue beat(2)34.98%
Revenue beat(4)2
Avg Revenue beat(4)6.72%
Min Revenue beat(4)-10.9%
Max Revenue beat(4)34.98%
Revenue beat(8)5
Avg Revenue beat(8)4.66%
Revenue beat(12)5
Avg Revenue beat(12)0.71%
Revenue beat(16)6
Avg Revenue beat(16)0.36%
PT rev (1m)71.21%
PT rev (3m)197.37%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.35%
EPS NY rev (1m)-450%
EPS NY rev (3m)88.87%
Revenue NQ rev (1m)-4.19%
Revenue NQ rev (3m)-12.48%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.71%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 27.25
P/FCF N/A
P/OCF N/A
P/B 13.75
P/tB 13.75
EV/EBITDA N/A
EPS(TTM)-0.44
EYN/A
EPS(NY)-0.02
Fwd EYN/A
FCF(TTM)-0.35
FCFYN/A
OCF(TTM)-0.29
OCFYN/A
SpS1.67
BVpS3.3
TBVpS3.3
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -6.88%
ROE -12.83%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 11.97%
FCFM N/A
ROA(3y)-4.47%
ROA(5y)-0.97%
ROE(3y)-7.58%
ROE(5y)-1.78%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-29.88%
GM growth 5Y-16.71%
F-Score2
Asset Turnover0.27
Health
Industry RankSector Rank
Debt/Equity 0.35
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 34.67%
Cap/Sales 3.46%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.76
Quick Ratio 0.85
Altman-Z 7.97
F-Score2
WACC10.96%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-83.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
EPS Next Y94.9%
EPS Next 2Y68.18%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-11.11%
Revenue growth 3Y-14.46%
Revenue growth 5Y-1.53%
Sales Q2Q%-8.22%
Revenue Next Year35.14%
Revenue Next 2Y32.81%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-99.28%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year147.04%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-12.34%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-32.2%
OCF growth 3YN/A
OCF growth 5YN/A

AXT INC / AXTI FAQ

What is the fundamental rating for AXTI stock?

ChartMill assigns a fundamental rating of 2 / 10 to AXTI.


Can you provide the valuation status for AXT INC?

ChartMill assigns a valuation rating of 1 / 10 to AXT INC (AXTI). This can be considered as Overvalued.


How profitable is AXT INC (AXTI) stock?

AXT INC (AXTI) has a profitability rating of 0 / 10.


Can you provide the financial health for AXTI stock?

The financial health rating of AXT INC (AXTI) is 3 / 10.


Can you provide the expected EPS growth for AXTI stock?

The Earnings per Share (EPS) of AXT INC (AXTI) is expected to grow by 94.9% in the next year.